Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Antioxid Redox Signal ; 23(9): 711-23, 2015 Sep 20.
Artículo en Inglés | MEDLINE | ID: mdl-25764009

RESUMEN

AIMS: Vascular oxidative stress generated by endothelial NO synthase (eNOS) was observed in experimental and clinical cardiovascular disease, but its relative importance for vascular pathologies is unclear. We investigated the impact of eNOS-dependent vascular oxidative stress on endothelial function and on neointimal hyperplasia. RESULTS: A dimer-destabilized mutant of bovine eNOS where cysteine 101 was replaced by alanine was cloned and introduced into an eNOS-deficient mouse strain (eNOS-KO) in an endothelial-specific manner. Destabilization of mutant eNOS in cells and eNOS-KO was confirmed by the reduced dimer/monomer ratio. Purified mutant eNOS and transfected cells generated less citrulline and NO, respectively, while superoxide generation was enhanced. In eNOS-KO, introduction of mutant eNOS caused a 2.3-3.7-fold increase in superoxide and peroxynitrite formation in the aorta and myocardium. This was completely blunted by an NOS inhibitor. Nevertheless, expression of mutant eNOS in eNOS-KO completely restored maximal aortic endothelium-dependent relaxation to acetylcholine. Neointimal hyperplasia induced by carotid binding was much larger in eNOS-KO than in mutant eNOS-KO and C57BL/6, while the latter strains showed comparable hyperplasia. Likewise, vascular remodeling was blunted in eNOS-KO only. INNOVATION: Our results provide the first in vivo evidence that eNOS-dependent oxidative stress is unlikely to be an initial cause of impaired endothelium-dependent vasodilation and/or a pathologic factor promoting intimal hyperplasia. These findings highlight the importance of other sources of vascular oxidative stress in cardiovascular disease. CONCLUSION: eNOS-dependent oxidative stress is unlikely to induce functional vascular damage as long as concomitant generation of NO is preserved. This underlines the importance of current and new therapeutic strategies in improving endothelial NO generation.


Asunto(s)
Endotelio Vascular/metabolismo , Neointima/metabolismo , Óxido Nítrico Sintasa de Tipo III/metabolismo , Estrés Oxidativo , Alanina/metabolismo , Animales , Aorta/metabolismo , Bovinos , Citrulina/metabolismo , Cisteína/metabolismo , Células HEK293 , Humanos , Ratones Endogámicos C57BL , Ratones Noqueados , Miocardio/metabolismo , Óxido Nítrico Sintasa de Tipo III/genética , Superóxidos/metabolismo , Vasodilatación
2.
Development ; 141(3): 685-96, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24449844

RESUMEN

Delamination plays a pivotal role during normal development and cancer. Previous work has demonstrated that delamination and epithelial cell movement within the plane of an epithelium are associated with a change in cellular phenotype. However, how this positional change is linked to differentiation remains unknown. Using the developing mouse pancreas as a model system, we show that ß cell delamination and differentiation are two independent events, which are controlled by Cdc42/N-WASP signaling. Specifically, we show that expression of constitutively active Cdc42 in ß cells inhibits ß cell delamination and differentiation. These processes are normally associated with junctional actin and cell-cell junction disassembly and the expression of fate-determining transcription factors, such as Isl1 and MafA. Mechanistically, we demonstrate that genetic ablation of N-WASP in ß cells expressing constitutively active Cdc42 partially restores both delamination and ß cell differentiation. These findings elucidate how junctional actin dynamics via Cdc42/N-WASP signaling cell-autonomously control not only epithelial delamination but also cell differentiation during mammalian organogenesis.


Asunto(s)
Actinas/metabolismo , Diferenciación Celular , Células Secretoras de Insulina/metabolismo , Células Secretoras de Insulina/patología , Transducción de Señal , Proteína Neuronal del Síndrome de Wiskott-Aldrich/metabolismo , Proteína de Unión al GTP cdc42/metabolismo , Animales , Animales Recién Nacidos , Embrión de Mamíferos/metabolismo , Embrión de Mamíferos/patología , Epitelio/metabolismo , Humanos , Hiperglucemia/metabolismo , Hiperglucemia/patología , Uniones Intercelulares/metabolismo , Uniones Intercelulares/patología , Ratones , Ratas , Imagen de Lapso de Tiempo
3.
Dev Biol ; 355(1): 124-37, 2011 Jul 01.
Artículo en Inglés | MEDLINE | ID: mdl-21539829

RESUMEN

During mammalian ocular development, several signaling pathways control the spatiotemporal highly defined realization of the three-dimensional eye architecture. Given the complexity of these inductive signals, the developing eye is a sensitive organ for several diseases. In this study, we investigated a Dkk1+/- haploinsufficiency during eye development, resulting in coloboma and anterior eye defects, two common developmental eye disorders. Dkk1 impacts eye development from a defined developmental time point on, and is critical for lens separation from the surface ectoderm via ß-catenin mediated Pdgfrα and E-cadherin expression. Dkk1 does not impact the dorso ventral retina patterning in general but is critical for Shh dependent Pax2 extension into the midline region. The described results also indicate that the retinal Dkk1 dose is critical for important steps during eye development, such as optic fissure closure and cornea formation. Further analysis of the relationship between Dkk1 and Shh signaling revealed that Dkk1 and Shh coordinatively control anterior head formation and eye induction. During eye development itself, retinal Dkk1 activation is depending on cilia mediated Gli3 regulation. Therefore, our data essentially improve the knowledge of coloboma and anterior eye defects, which are common human eye developmental defects.


Asunto(s)
Ojo/crecimiento & desarrollo , Péptidos y Proteínas de Señalización Intercelular/fisiología , Animales , Cadherinas/biosíntesis , Coloboma/genética , Coloboma/fisiopatología , Modelos Animales de Enfermedad , Ectodermo/crecimiento & desarrollo , Ectodermo/fisiopatología , Anomalías del Ojo/genética , Anomalías del Ojo/fisiopatología , Femenino , Regulación del Desarrollo de la Expresión Génica , Haploinsuficiencia , Proteínas Hedgehog/fisiología , Péptidos y Proteínas de Señalización Intercelular/genética , Factores de Transcripción de Tipo Kruppel/fisiología , Masculino , Ratones , Proteínas del Tejido Nervioso/fisiología , Factor de Transcripción PAX2/fisiología , Receptor alfa de Factor de Crecimiento Derivado de Plaquetas/biosíntesis , Proteína Gli3 con Dedos de Zinc , beta Catenina/metabolismo
4.
Int J Cancer ; 118(3): 577-82, 2006 Feb 01.
Artículo en Inglés | MEDLINE | ID: mdl-16094622

RESUMEN

The abrogation of the function of the "gatekeeper of the genome", p53, is the most prevalent molecular alteration in solid human tumors. Regarding melanomas the involvement of p53 alterations is discussed controversially to date. In order to evaluate the status of p53 in detail, primary tumors and metastases of 63 sporadic cutaneous (CM) and mucosal (MuM) melanomas were examined by immunohistochemistry and sequence analysis of the entire coding region of the p53 transcript, i.e., exons 2 to 11. In addition, loss of heterozygosity (LOH) and loss of allele-specific transcription (LOT) were determined. Accumulation of the p53 protein occurred in most of the CM and MuM specimens (71% and 58%, respectively). In contrast, protein stabilizing p53 mutations were observed in 14% of the CM and no mutation was found in MuM specimens. Two of the aberrations located outside the core domain. LOH was detected in 22% CM and 58% MuM, and LOT in 25% of the CM specimens. The genotype distribution at the polymorphic p53 codon 72 in melanoma patients differed significantly from control subjects. The calculation of odds ratios (OR) and 95% confidence intervals (CI) indicated an increased risk for developing cutaneous melanomas in individuals carrying the Pro-coding allele. Altogether, aberrant p53 expression appears to be a common event in both CM and MuM.


Asunto(s)
Melanoma/metabolismo , Neoplasias Nasales/metabolismo , Neoplasias Cutáneas/metabolismo , Proteína p53 Supresora de Tumor/metabolismo , Anciano , Alelos , ADN de Neoplasias/análisis , Femenino , Genes p53/fisiología , Genotipo , Humanos , Pérdida de Heterocigocidad , Masculino , Mutación/genética , Mucosa Nasal/metabolismo , Mucosa Nasal/patología , Oportunidad Relativa , Sistemas de Lectura Abierta/genética , Factores de Riesgo , Transcripción Genética , Proteína p53 Supresora de Tumor/genética
5.
Cancer Epidemiol Biomarkers Prev ; 13(11 Pt 1): 1805-9, 2004 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-15533911

RESUMEN

A polymorphism at codon 72 of the human tumor suppressor p53 determines translation into either arginine or proline. Yet, the impact of this amino acid variability on the risk to develop malignant tumors, particularly carcinomas associated with human papilloma virus (HPV) infections, remains unresolved because of contradictory results. To address a potential correlation between the different genotypes and the manifestation of squamous cell carcinomas of the head and neck (SCCHN), we determined the p53 codon 72 in 193 healthy subjects and 122 unselected SCCHN with known HPV status. Furthermore, loss of allele-specific transcription was analyzed in p53 codon 72 heterozygous (Arg/Pro) SCCHN and correlated with HPV 16 and/or 18 E6 transcript expression. We found a moderately increased risk (odds ratio, 1.86; 95% confidence interval, 1.0-3.3) for individuals with germ line heterozygosity to develop SCC of the pharynx. On the other hand, p53 codon 72 polymorphic variants, most notably the Arg/Arg genotype, showed no association with the presence of HPV 16 and/or 18 E6 transcript. Moreover, there was no evidence for HPV-driven selection in SCCHN with allele-specific loss of transcription. Our data suggest that the p53 codon 72 polymorphism has a minor impact on the development of SCCHN.


Asunto(s)
Carcinoma de Células Escamosas/genética , Neoplasias de Cabeza y Cuello/genética , Proteínas Oncogénicas Virales , Proteína p53 Supresora de Tumor/genética , Adulto , Anciano , Carcinoma de Células Escamosas/virología , Estudios de Casos y Controles , Femenino , Genotipo , Neoplasias de Cabeza y Cuello/virología , Humanos , Masculino , Persona de Mediana Edad , Polimorfismo Genético , ARN Mensajero/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA